Evidence map›Paper›PMID 23307014›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2013

Human 5-HT₄receptor stimulation in atria of transgenic mice.

Ulrich Gergs, Anne Böckler, Henning Ebelt, Steffen Hauptmann, Nicolas Keller, Volker Otto, Klaus Pönicke, Wilhelm Schmitz, Joachim Neumann

Abstract read
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 59 citations in OpenAlex.

  1. Prokinetic drugs that stimulate 5-HTNaunyn-Schmiedeberg's archives of pharmacology · 2026
    Review
  2. Article
  3. Felcisetrag stimulates 5-HTNaunyn-Schmiedeberg's archives of pharmacology · 2026
    Article
  4. Initial characterization of MNaunyn-Schmiedeberg's archives of pharmacology · 2026
    Article
  5. Article
  6. Temperature alters the inotropic and chronotropic effect of DNaunyn-Schmiedeberg's archives of pharmacology · 2025
    Article
  7. Contractile effects of dexmedetomidine in the human heart.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Article
  8. Clebopride stimulates 5-HTNaunyn-Schmiedeberg's archives of pharmacology · 2025
    Article
  9. Bromopride stimulates 5-HTNaunyn-Schmiedeberg's archives of pharmacology · 2025
    Article
  10. Clozapine is a functional antagonist at cardiac human HNaunyn-Schmiedeberg's archives of pharmacology · 2025
    Article
  11. Article
  12. Studies on the mechanisms of action of MR33317.Naunyn-Schmiedeberg's archives of pharmacology · 2024
    Article
  13. Zacopride stimulates 5-HTNaunyn-Schmiedeberg's archives of pharmacology · 2024
    Article
  14. Mosapride stimulates human 5-HTNaunyn-Schmiedeberg's archives of pharmacology · 2024
    Article
  15. Article
  16. Initial characterization of a transgenic mouse with overexpression of the human DNaunyn-Schmiedeberg's archives of pharmacology · 2024
    Article
  17. Article
  18. Review
  19. Lysergic acid diethylamide stimulates cardiac human HNaunyn-Schmiedeberg's archives of pharmacology · 2024
    Article
  20. OR-1896 increases force of contraction in the isolated human atrium.Naunyn-Schmiedeberg's archives of pharmacology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Ulrich GergsInstitut für Pharmakologie und Toxikologie, Medizinische Fakultät, Martin-Luther-Universität Halle-Wittenberg, Magdeburger Str. 4, 06112 Halle, Germany. ulrich.gergs@medizin.uni-halle.de
Anne Böckler
Henning Ebelt
Steffen Hauptmann
Nicolas Keller
Volker Otto
Klaus Pönicke
Wilhelm Schmitz
Joachim Neumann
Martin Luther University Halle-Wittenberg · DEUniversity Hospital Münster · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In human atrium, serotonin (5-HT) exerts pleiotropic effects, which are thought to be mediated via 5-HT4 receptors. Here, we used transgenic mice (TG) that overexpress the human 5-HT4(a) receptor under control of the heart-specific α-myosin heavy chain promoter in the atria (and ventricles). Contractile studies were performed in isolated electrically driven left atrial preparations and spontaneously beating right atrial preparation of TG and littermate control mice (wild type (WT)). 5-HT increased force of contraction and phospholamban phosphorylation on serine 16 only in left atrial preparations from TG but not from WT. In contrast, β-adrenoceptor stimulation of left atrial preparations by isoprenaline increased force of contraction with similar pEC50 values and to a similar maximum extent in both TG and WT. The contractile effects of 5-HT in left atrial preparations from TG could be blocked by the 5-HT4 receptor-specific antagonists GR125487 or GR113808. In right atrial preparations from WT and TG, the β-adrenoceptor agonist isoprenaline exerted a positive chronotropic effect with similar pEC50 values and similar maximum effects. Only in right atrial preparations from TG but not WT, 5-HT exerted a positive chronotropic effect that could be attenuated by 5-HT4 receptor-specific antagonists. Finally, in left atrial preparations of TG, a higher incidence of arrhythmias was noted compared to WT. The present data indicate that the human 5-HT4 receptors expressed in mouse atria are functional. This is the first transgenic model to study this human receptor in the atrium ex vivo or in vivo.

Indexed as

AnimalsAtrial FunctionHeart AtriaHumansIsoproterenolMiceMice, TransgenicMyocardial ContractionOrgan Culture TechniquesReceptors, Serotonin, 5-HT4SerotoninIsoproterenolReceptors, Serotonin, 5-HT4Serotonin

Identifiers

PMID23307014
OpenAlexW2153019281

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.